Table 1.
Perspective | Benefit categories | Definition | Individual | Household | Community | Employer | Insurer | MoH | Government | |
---|---|---|---|---|---|---|---|---|---|---|
Broad & Narrow | Health care cost savings | Savings of medical expenditures because vaccination prevents illness episodes | x | x | ||||||
Care-related productivity gains | Savings of patients’ and caretaker’s productive time because vaccination avoids the need for care and convalescence | x | x | x | ||||||
Broad | Outcome-related productivity gains | Increased productivity because vaccination improves physical and/or mental health | x | |||||||
Behaviour-related productivity gains | Vaccination improves health and survival, and may thereby change individual behaviour, for example by lowering fertility or increasing investment in education | x | x | x | ||||||
Health care externalities | Vaccination improves the quality delivery of health care during disease peak periods among those treated for other reasons | x | ||||||||
Community health externalities | Improved outcomes in unvaccinated community members, e.g., through herd effects or reduction in the rate at which resistance to antibiotics develops | x | x | x | x | |||||
Community economic externalities | Higher vaccination rates can affect macroeconomic performance and social and political stability; avoid poverty traps | x | x | x | ||||||
Risk reduction gains | Gains in welfare because uncertainty in future outcomes is reduced | x | x | x | ||||||
Health gains | Utilitarian value of reductions in morbidity and mortality above and beyond their instrumental value for productivity and earnings | x | x | x |
MoH, Ministry of Health